Company intelligence / Profile preview

Visionary Holdings

Toronto, Ontario, Canadathinkvisionary.com ↗

Ownership: Private
Development stage: Other

Overview

Visionary Holdings has developed world-class biochip products for medical diagnostics and precision medicine applications. The company is advancing next-generation immunotherapies, gene editing tools, rapid at-home testing for cancers such as cervical and colorectal cancers, and liquid biopsy technologies. It is also co-developing third-generation EGFR inhibitors currently in global clinical trials targeting drug-resistant non-small cell lung cancer.

Therapeutic areas: OncologyGastroenterologyWomen's Health
Modalities: Biochip technologySmall molecule (e.g., kinase inhibitors)Diagnostic deviceGene editing technologies
Industry: Biotech

Partnerships

Canada BRAUN Bio Technology Group Inc.Red Sun GroupFarnova Holding Groupmultiple international research institutions

Beyond the preview

Go deeper on Visionary Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visionary Holdings.

Explore the full profile